Skip to main content

UBS Group AG

Position in NMRA — Neumora Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in NMRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$244,332
+$128,145 QoQ
Shares Held
143,725
+141.2% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 111 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NMRA Over Time

Shares Held

Position Value (USD)

Derivatives in NMRA

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$127,200
PutShares
12,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. NMRA ranks #329 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NMRA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $244,332 143,725
2026-03-31 $116,187 59,584
2025-12-31 $169,881 94,906
2025-09-30 $234,863 129,046
2025-06-30 $476,964 650,704
2025-03-31 $3,106,556 3,106,556
2024-12-31 $13,164,616 1,241,945
2024-12-31 $127,200 12,000
2024-09-30 $4,487,052 339,671
2024-06-30 $2,906,307 295,657
2024-03-31 $347,613 25,281
2023-12-31 $4,364 256